Liu, PengRoberts, SophieShoemaker, James TVukasinovic, JelenaTomlinson, Darren C.Speirs, Valerie2023-05-092023-05-092023-03-16Liu, P, Roberts, S, Shoemaker, J T, Vukasinovic, J, Tomlinson, D C & Speirs, V 2023, 'Validation of a 3D perfused cell culture platform as a tool for humanised preclinical drug testing in breast cancer using established cell lines and patient-derived tissues', PloS ONE, vol. 18, no. 3, 0283044. https://doi.org/10.1371/journal.pone.02830441932-6203ORCID: /0000-0002-0602-4666/work/131842190https://hdl.handle.net/2164/20688Open Access via the PLOS Agreement Funding: This study was funded by NC3Rs studentship (NC/N00325X/1), NC3Rs/CRUK Skills and Capacity award (NC/T001259/1), the University of Aberdeen Development Trust, and the NIH SBIR Phase I and Phase II grants: 1R43TR001286, 2R44TR001286, and 5R44TR001286 awarded to Lena Biosciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.132188820engSDG 3 - Good Health and Well-beingR MedicineNational Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3R's)NC/N00325X/1NC/T001259/1RValidation of a 3D perfused cell culture platform as a tool for humanised preclinical drug testing in breast cancer using established cell lines and patient-derived tissuesJournal article10.1371/journal.pone.0283044183